Last reviewed · How we verify

NCT04078503: Delirium-fMRI

Neuroinflammation During ICU-associated Delirium in Critically Ill Patients and Its Association With Structural and Functional Brain Alterations: a Nested Case-control Study

Status unknown Last updated 6 September 2019
What this trial tests

trial in Delirium in 60 participants. Status unknown.

Timeline
25 March 2019
Primary endpoint
25 March 2021
25 June 2021

Quick facts

Lead sponsorAzienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment60
Start date25 March 2019
Primary completion25 March 2021
Estimated completion25 June 2021
Sites1 location across Italy

Conditions studied

Sponsor

Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia — full company profile →

Who can join

18 and older, any sex, with Delirium or Critical Illness. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

With the present study, the authors aim to improve the knowledge of the pathophysiology of ICU-related delirium. In particular, the authors would like to clarify the possible correlation between neuroinflammation, evaluated longitudinally by serum dosage of 20 different neuroinflammation biomarkers, and brain structural and functional alterations (using brain fMRI).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Delirium

Currently open trials in the same condition.

Other Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04078503.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing